Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
Next Generation Sequencing
Proteomics
Biopharmaceuticals
Instrumentation & Equipment
Emerging Technologies
- Display 30 Products per page
Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...Published: September 7, 2022 | Price: $0.00 – $9,000.00
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which...Published: January 1, 2011 | Price: $150.00 – $300.00
Sample preparation and library preparation are important steps in the DNA sequencing process with specialized products and companies. Based on a survey of labs worldwide conducted by Kalorama's biotech analyst Justin Saeks, this report provides detailed information on the current state of DNA sequencing sample preparation and library preparation for next-generation systems, as well as sample preparation, cycle sequencing and sequencing reaction cleanup with capillary systems. The report's perspective is demand-side, focusing on what labs are doing today. The information...Published: May 1, 2011 | Price: $150.00 – $300.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead the market now and what can we expect to see in the coming years? Find out in Kalorama Information's report, What's Next in Biologics?, which represents our latest research into the market for non-vaccine biological...Published: November 1, 2011 | Price: $150.00 – $300.00
DNA Microarrays are utilized heavily by research labs for a number of tasks such as gene profiling, RNA detection and SNP analysis. But as Kalorama Information's DNA Market Trends report indicates, the market for these systems is about to experience change. The report authored by Kalorama Information biotech analyst Justin Saeks, is the result of surveys carried out with microarray labs to determine the current state of the microarray market and attempt to predict the future direction of the technologies....Published: October 15, 2011 | Price: $150.00 – $300.00
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects. Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological...Published: March 1, 2003 | Price: $250.00 – $5,250.00
The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where chips were initially envisioned as carriers of microscopic binding sites...Published: August 17, 2015 | Price: $499.00 – $1,000.00
What’s happening in biotechnology in the fastest-growing economies of the world? Who are the leaders operating in these nations and what partnerships have they completed? This report provides answers and informs readers of the companies they need to know about. Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today’s biotech market in the countries outside the United States and Europe. The report identifies eight important emerging company markets and...Published: August 24, 2015 | Price: $499.00 – $1,000.00
The Worldwide Market for Bioreactors The essential equipment needed for bioprocessing is the fermenter or bioreactor. Bioreactors are manufactured vessels or systems that support a biologically active environment, as cells require a very specific environment in which to grow. These bioreactors usually range in size from liters to cubic meters, and are often made of stainless steel for the large scale production of therapeutics. In the biopharmaceutical arena, smaller glass bioreactors usually are intended for research work and process development...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: September 1, 2005 | Price: $795.00 – $1,590.00
One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...Published: April 26, 2016 | Price: $796.00 – $6,720.00
qPCR and dPCR Markets (Instruments, Reagents, Software/Services) This Kalorama Information study, qPCR and dPCR, analyzes the market for these workhorse technnologies in detail, providing detailed market sizing and forecasts for both the research and clinical PCR market are provided to 2020. Trends are discusssed, competitors profiled and useful business planning data provided. The report estimates markets and forecasts markets for reagents, instruments, software/services used in PCR. Regions covered include: US, Europe, Asia and Rest of World.Published: September 1, 2004 | Price: $895.00 – $1,790.00
Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer therapeutics, specialized drug delivery, diagnostics, and topical therapies, reviewing what companies are doing in those markets.Published: June 1, 2006 | Price: $995.00 – $7,800.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas: Monoclonal Antibodies Erythropoietins Insulin Interferons Growth Factors Interleukins Blood Clotting Factors Tissue Plasminogen Activator Human Growth Hormones Reproductive Hormones Recombinant BMP-2...Published: November 1, 2006 | Price: $995.00 – $5,990.00
Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical,...Published: January 1, 2007 | Price: $995.00 – $3,990.00
Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials. Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only...Published: May 1, 2007 | Price: $995.00 – $3,990.00
Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market from Kalorama Information. One of the most promising new approaches in modern cancer treatment is immunotherapy, the development of methods to augment and enhance the...Published: January 1, 2008 | Price: $995.00 – $7,990.00
Parts of the gene expression analysis market continue to develop in a somewhat predictable manner, whereas other segments are becoming increasingly complex and volatile. The main products—microarrays and RT-PCR—continue to gain widespread acceptance and to see revenues grow rapidly. However, different products and applications are increasingly being introduced, making the market more fragmented as well as unpredictable. In terms of application, too, the landscape is shifting. Although life-science research is still the dominant application, the clinical diagnostics and prognostics market...Published: March 1, 2008 | Price: $995.00 – $7,800.00
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug...Published: December 1, 2008 | Price: $995.00 – $1,990.00
The substances utilized for what is commonly referred to as 'protein therapeutics' have one thing in common --- they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a variety of areas of medicine, they are among the most interesting pharmaceutical markets. Above-Average Growth Rates What makes protein therapeutics interesting? The market for protein-based therapeutics is one that is significant in its size...Published: December 1, 2008 | Price: $995.00 – $1,990.00
Biophotonics describes the use of photonics in biomedical applications. There are several key areas that are associated with biophotonics. All of these center on microscopy and related technology. The reason that this is so is that biophotonics look at biological functions at the cellular level, or even smaller. The only way that these processes can be observed is via one or another form of microscopy. Among the different types of microscopy and associated technologies essential to the applications of biophotonics...Published: February 1, 2009 | Price: $995.00 – $5,000.00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ability to differentiate and become an ongoing source of cells...Published: April 1, 2009 | Price: $995.00 – $7,000.00
Pharmacodiagnostics are considered the pathway to what has been termed "personalized medicine," the use of molecular analysis to achieve optimum medical outcomes in the management of a patient’s disease or predisposition to disease. As such, personalized medicine promises to bring about a new standard of healthcare, with the possiblity to increase profits, speed clinical trials, achieve better clinical results and satisfy patients. But how can companies earn revenue in this undertaking? What are the likely challenges for pharma companies and...Published: May 1, 2009 | Price: $995.00 – $7,990.00
Worldwide cancer affects more than 10 million people each year. This number is expected to increase by 2.4% by 2020 to 14 million each year. Worldwide approximately 22 million people are living with cancer and nearly 7 million people die. The most common cancers affecting the world include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics - focuses on several segments for cancer treatment. The...Published: August 10, 2012 | Price: $995.00 – $1,990.00
Epigenetics (“Epi”; “over “ or “above” genetics) is recognized as those systems that control the expression of DNA-coded genes, but do not reside in the base pair sequences of the DNA. Rather, these control mechanisms are based on factors or molecules that bind to specific regions of the DNA (the genome), affecting gene expression. The three most important, and best understood mechanisms, are: Methylation, Histone Modulation and Micro RNA (or miRNA) Regulation This report an assessment of commercial outlook for...Published: June 7, 2013 | Price: $995.00 – $2,000.00
Computer diagnostics could offer opportunity for clinical laboratory professionals to add value to clinicians in diagnosing diseases. IT companies in collaboration with test vendors are developing computer software that complements the skills of human test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis and therapy management. In infectious disease diagnostics it allows the detection of...Published: January 23, 2014 | Price: $995.00 – $1,990.00
Next-Generation Sequencing in Latin America This report is an examination of the use of DNA sequencing systems in the Latin American region, based on a survey conducted in Fall 2013 by VA Consultadoros. The survey centered on instrumentation, with a goal of providing a complete count of next-generation sequencing (NGS) systems sold to customers in the major countries of Latin American. For the healthcare industry, Latin America is a focus. The region went through its highest economic growth period in...Published: May 20, 2014 | Price: $995.00 – $1,990.00
Recent Biotech Funding, Deals and Partnerships Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years, and 2013 saw a notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this influx of corporate capital, biotechnology companies have seen a significant influx...Published: September 4, 2014 | Price: $995.00 – $1,990.00
miRNA Research and Diagnostics Markets This report, miRNA Research and Diagnostic Markets, focuses on the test product potential of microRNA. These pieces of RNA are seen as important regulators of gene expression; including growth, form, differentiation, and apoptosis. They serve myriad functions as regulator molecules in post-transcriptional gene silencing. As the study details, a wide range of companies, both small biotechs and big pharmaceutical companies are committed to miRNA diagnostics. As part of its coverage of this topic, this report...Published: October 9, 2014 | Price: $995.00 – $7,990.00
Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products. Kalorama Information’s Stem Cell Therapeutics Markets is a complete analysis of stem cell drugs now and in development. The report estimates the opportunity by for novel technologies through an assessment of current products, pipeline, cost trends and regulation. Bottom-up and Top-Down analysis was used to determine market size and market forecasts. Over the next several years, as researchers introduce a growing variety...